Head of the Independent Research Group at the Regional Center for Digital Medicine (SGB RCDM). She graduated in Biotechnology from Adam Mickiewicz University in Poznań and completed studies in Research and Development Project Management at the WSB University in Poznań. She has been affiliated with the Institute of Human Genetics PAS (IHG PAS) since 1997, where she completed her master’s and her doctoral work, earning her PhD in Medical Sciences in 2010. Her doctoral dissertation was awarded first prize by the Polish Society of Hypertension. She obtained the title of habilitated Doctor in Medical Sciences in 2019 at the same institution.
Her main research interests focus on personalized and translational medicine in cardiovascular diseases and conditions related to preterm birth. For 20 years, she has been involved in national and international scientific collaborations on genetic research into the pathogenesis and progression of abdominal aortic aneurysms (AAA). She directly collaborates with centers in the USA (Sigfried and Janet Weis Center for Research, Geisinger Health System), the United Kingdom (University of Oxford and University of Leicester), and Sweden (Karolinska University). For her research on the genetic background of AAA in the Polish population, she received the prestigious Camillo Di Croce Award at the International Meeting on Aortic Disease in Belgium and has twice been a recipient of awards from the Polish Society for Vascular Surgery. She was also awarded the Teaching Prize from the Polish Society of Human Genetics for translating the medical genetics textbook Human Genetics: Problems and Approaches (PWN Scientific Publishers), authored by Bruce R. Korf, for medical students.
In translational research, she led an interdisciplinary scientific team in the MEDPIG NCBiR, INNOMED project (2012-2018), which focused on the use of vascular and skin xenografts for the treatment of peripheral artery disease and ischemic wounds in humans. Currently, in the field of translational research, she is working on the NetZeroAICT project, which aims to replace contrast agents in computed tomography (CT) scans with an AI algorithm (“artificial contrast”). This project is funded by Horizon Europe (2023-2028; https://netzeroaict.eu/) and is led by researchers from Oxford.
Currently, as part of her research activities, she is involved in establishing a DNA sample repository and DNA sequence biobank at the IHG PAS, implementing new analytical techniques such as emulsion PCR and nanopore sequencing, and developing bioinformatics tools and AI algorithms for the analysis of genetic and medical data. A significant aspect of her research is its interdisciplinarity, encompassing the integration of omics research results with digital histopathology, clinical phenotype, and imaging study outcomes, including CT scans and ultrasound examinations.